secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0001493152-23-009596
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD Q4 revenue down 20.6% YoY; net loss widens to $4.8M; resumes CGuard shipments under MDD
--------------------------------------------------------------------------------

- Q4 CGuard revenue $1.026M (-20.6% YoY) due to temporary CE Mark expiration; full year revenue $5.123M (+18.9%).
- Net loss Q4 $4.845M ($0.60/share) vs $4.097M ($0.53) in Q4 2021; full year net loss $18.491M ($2.35/share).
- Cash and equivalents $17.8M at Dec 31, 2022, down from $34.0M a year ago.
- Resumed CGuard shipments to CE Mark territories in mid-March 2023 under MDD; expects MDR recertification in coming weeks.
- US IDE trial enrollment on track to complete by end of Q2 2023; 20 sites currently enrolling.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315223009596/0001493152-23-009596-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315223009596/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-009596

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer